home / stock / cerc / cerc quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2021-03-01 | 3.54 | 3.73 | 3.743 | 3.5 | 526,452 |
2021-02-26 | 3.58 | 3.37 | 3.7 | 3.36 | 1,194,334 |
2021-02-25 | 3.9 | 3.64 | 3.9 | 3.53 | 548,071 |
2021-02-24 | 3.78 | 3.89 | 3.98 | 3.74 | 559,770 |
2021-02-23 | 3.85 | 3.67 | 3.85 | 3.5 | 1,021,606 |
2021-02-22 | 4.27 | 4.05 | 4.5 | 4.0285 | 951,168 |
2021-02-19 | 4.08 | 4.34 | 4.45 | 4.08 | 1,530,494 |
2021-02-18 | 4.15 | 4.07 | 4.27 | 3.99 | 789,824 |
2021-02-17 | 4.16 | 4.17 | 4.295 | 4.025 | 1,136,470 |
2021-02-16 | 3.983 | 4.18 | 4.32 | 3.96 | 1,324,071 |
2021-02-15 | 3.83 | 3.96 | 3.99 | 3.68 | 1,188,998 |
2021-02-12 | 3.83 | 3.96 | 3.99 | 3.68 | 1,138,656 |
2021-02-11 | 3.77 | 3.64 | 3.87 | 3.58 | 537,827 |
2021-02-10 | 3.88 | 3.74 | 4.09 | 3.7 | 1,197,583 |
2021-02-09 | 3.65 | 3.88 | 3.94 | 3.65 | 1,081,892 |
2021-02-08 | 3.43 | 3.63 | 3.65 | 3.43 | 791,423 |
2021-02-05 | 3.44 | 3.44 | 3.49 | 3.35 | 625,014 |
2021-02-04 | 3.23 | 3.42 | 3.42 | 3.22 | 1,070,149 |
2021-02-03 | 3.21 | 3.23 | 3.3 | 3.2 | 846,731 |
2021-02-02 | 3.2 | 3.22 | 3.3 | 3.13 | 915,298 |
News, Short Squeeze, Breakout and More Instantly...
Final analysis inclusive of the 60-day safety update in the randomized placebo-controlled study demonstrated CERC-002 was statistically significant in reducing respiratory failure and mortality at Day 28 in patients hospitalized with COVID-19 associated pneumonia and mild to moderate ac...
ROCKVILLE, Md. and CHESTERBROOK, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ:CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases, today announced the appointment of Schond L. Gre...
ROCKVILLE, Md., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases, today announced that the U.S. Food and Drug Administration (FDA) has grant...